The study was supported by a company that has combined the two drugs in ... mean weight loss was significantly greater in the high- and low-dose bupropion/naltrexone groups than in the placebo ...
Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents ... of the two component drugs will require careful ...
the association with bupropion and naltrexone became statistically insignificant when adjusted for weight loss. Researchers hypothesized that certain pharmacological properties of obesity drugs ...
The researchers compared the drugs to bupropion-naltrexone, the active ingredient in weight-loss drug Contrave, which was approved in 2014. A Novo Nordisk spokesperson noted that some of the ...
Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...
In a recent study published in the International Journal of Obesity, researchers investigated the effects of combined glucagon-like peptide 1 (GLP-1) analog and bupropion/naltrexone treatment on ...
Starting this medication before you’ve been sufficiently ... Does naltrexone cause certain side effects when taken for weight loss? Naltrexone is not approved for weight loss, so its prescribing ...
The weight loss medications on the market today are generally ... by 5.4 percent with liraglutide (Saxenda), 4 percent with naltrexone-bupropion (Contrave), and 2.9 percent with orlistat (Xenical).